TEMPUS AI, INC. CLASS A COMMON STOCK

NASDAQ: TEM (Tempus AI, Inc.)

Kemas kini terakhir: 26 Nov, 2:45PM

77.06

0.22 (0.28%)

  • 1H 0.28%
  • 5H -0.20%
  • 1B 7.35%
  • 6B 15.12%
  • Tahun Ke Tarikh 124.99%
  • 1T 65.72%
  • 5T 91.45%
Penutupan Terdahulu 76.84
Buka 77.84
Jumlah Dagangan 3,036,038
Purata Dagangan (3B) 7,560,893
Modal Pasaran 13,709,249,536
Harga / Jualan (P/S) 12.04
Harga / Buku (P/B) 26.24
Julat 52 Minggu
31.36 (-59%) — 104.32 (35%)
Tarikh Pendapatan 4 Nov 2025
Margin Keuntungan -88.27%
Margin Operasi (TTM) -26.93%
EPS Cair (TTM) -5.16
Pertumbuhan Hasil Suku Tahunan (YOY) 75.40%
Jumlah Hutang/Ekuiti (D/E MRQ) 262.96%
Nisbah Semasa (MRQ) 1.71
Aliran Tunai Operasi (OCF TTM) -193.29 M
Aliran Tunai Bebas Leveraj (LFCF TTM) 54.30 M
Pulangan Atas Aset (ROA TTM) -43.89%

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Health Information Services (US) Menurun Bercampur
Health Information Services (Global) Menurun Bercampur
Stok Tempus AI, Inc. Menaik Menaik

AISkor Stockmoo

0.5
Konsensus Penganalisis 4.0
Aktiviti Orang Dalam -3.0
Volatiliti Harga 2.0
Purata Bergerak Teknikal 1.5
Osilator Teknikal -2.0
Purata 0.50

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
TEM 14 B - - 26.24
GEHC 39 B 0.16% 17.69 3.66
HQY 8 B - 43.35 4.21
WAY 7 B - 54.32 2.09
BTSG 7 B - 65.85 3.55
RCM 6 B - - 2.14

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Sektor Healthcare
Industri Health Information Services
Gaya Pelaburan Mid Growth
% Dimiliki oleh Orang Dalam 43.27%
% Dimiliki oleh Institusi 38.33%
Julat 52 Minggu
31.36 (-59%) — 104.32 (35%)
Julat Harga Sasaran
80.00 (3%) — 105.00 (36%)
Tinggi 105.00 (BTIG, 36.26%) Beli
Median 95.00 (23.28%)
Rendah 80.00 (Piper Sandler, 3.82%) Pegang
Purata 92.71 (20.31%)
Jumlah 6 Beli, 1 Pegang
Harga Purata @ Panggilan 76.70
Syarikat Tarikh Harga Sasaran Panggilan Harga @ Panggilan
Morgan Stanley 02 Dec 2025 85.00 (10.31%) Beli 73.97
11 Nov 2025 80.00 (3.82%) Beli 71.56
BTIG 25 Nov 2025 105.00 (36.26%) Beli 76.84
05 Nov 2025 96.00 (24.58%) Beli 82.26
Piper Sandler 11 Nov 2025 80.00 (3.82%) Pegang 71.56
22 Oct 2025 105.00 (36.26%) Pegang 85.27
HC Wainwright & Co. 07 Nov 2025 89.00 (15.50%) Beli 71.56
12 Sep 2025 98.00 (27.18%) Beli 86.38
Canaccord Genuity 05 Nov 2025 95.00 (23.28%) Beli 82.26
20 Oct 2025 110.00 (42.75%) Beli 92.45
Needham 05 Nov 2025 100.00 (29.77%) Beli 82.26
Guggenheim 26 Sep 2025 95.00 (23.28%) Beli 78.48
Papar semua
Nama Purata Belian ($) Purata Jualan ($) Jumlah Net Jumlah Nilai Bersih ($)
FUKUSHIMA RYAN 76.84 76.84 -223,220 -17,152,225
LEFKOFSKY ERIC P - 76.06 -166,250 -12,644,975
POLOVIN ANDREW - 76.06 -12,874 -979,196
Jumlah Keseluruhan Kuantiti Bersih -402,344
Jumlah Keseluruhan Nilai Bersih ($) -30,776,396
Purata Pembelian Keseluruhan ($) 76.84
Purata Jualan Keseluruhan ($) 76.45
Nama Pemegang Tarikh Jenis Kuantiti Harga Nilai ($)
FUKUSHIMA RYAN Pegawai 25 Nov 2025 Dibuang (-) 125,135 76.84 9,615,373
FUKUSHIMA RYAN Pegawai 25 Nov 2025 Diperolehi (+) 33,808 76.84 2,597,807
FUKUSHIMA RYAN Pegawai 25 Nov 2025 Dibuang (-) 131,893 76.84 10,134,658
POLOVIN ANDREW Pegawai 24 Nov 2025 Jual automatik (-) 12,874 76.06 979,196
LEFKOFSKY ERIC P Pegawai 24 Nov 2025 Jual automatik (-) 166,250 76.06 12,644,975
  • 3M
Tarikh Jenis Butiran
18 Nov 2025 Pengumuman Tempus to Participate in the Piper Sandler 37th Annual Healthcare Conference
14 Nov 2025 Pengumuman Tempus and IFLI Announce Study to Advance Follicular Lymphoma Research
05 Nov 2025 Pengumuman Tempus Announces Six Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer Annual Meeting 2025
04 Nov 2025 Pengumuman Tempus Reports Third Quarter 2025 Results
28 Oct 2025 Pengumuman Tempus to Participate in the Stifel 2025 Healthcare Conference
21 Oct 2025 Pengumuman Tempus to Report Third Quarter 2025 Financial Results on November 4
20 Oct 2025 Pengumuman Ambry Genetics Announces 10-Year Study in Genetics in Medicine Highlighting the Impact of Proactive Exome Reanalysis for Healthcare Equity
16 Oct 2025 Pengumuman Tempus Announces Collaboration with Whitehawk Therapeutics to Advance Biomarker-Driven Oncology Research
15 Oct 2025 Pengumuman Tempus Announces Six Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2025
09 Oct 2025 Pengumuman Tempus Selected by ARPA-H to Provide CRO and Testing Services for the ADAPT Program, Advancing Precision Cancer Therapy
01 Oct 2025 Pengumuman Ambry Genetics Announces Improved EHR-Integrated Breast Cancer Risk Assessment Solution with Upgraded Tyrer-Cuzick Scoring Approach Incorporating Breast Density
22 Sep 2025 Pengumuman Tempus Receives U.S. FDA 510(k) Clearance for Tempus xR IVD, its RNA NGS In Vitro Diagnostic Device
15 Sep 2025 Pengumuman Renalytix Announces Collaboration with Tempus to Advance Intelligent Risk Assessment in Diabetic Kidney Disease
11 Sep 2025 Pengumuman Tempus Receives U.S. FDA Special 510(k) Clearance for Updated Tempus Pixel Device
09 Sep 2025 Pengumuman Tempus Announces New Study in JCO Precision Oncology Validating PurIST® Algorithm for Enhanced Therapy Selection in Pancreatic Cancer
Papar semua

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2025 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda